SK262002A3 - Cyclic peptide derivatives as inhibitors of integrin alpha'v'beta'6' - Google Patents

Cyclic peptide derivatives as inhibitors of integrin alpha'v'beta'6' Download PDF

Info

Publication number
SK262002A3
SK262002A3 SK26-2002A SK262002A SK262002A3 SK 262002 A3 SK262002 A3 SK 262002A3 SK 262002 A SK262002 A SK 262002A SK 262002 A3 SK262002 A3 SK 262002A3
Authority
SK
Slovakia
Prior art keywords
asp
arg
leu
gly
ala
Prior art date
Application number
SK26-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Alfred Jonczyk
Beate Diefenbach
Simon Goodman
Ulrich Groth
Gunther Zischinsky
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK262002A3 publication Critical patent/SK262002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK26-2002A 1999-07-15 2000-07-03 Cyclic peptide derivatives as inhibitors of integrin alpha'v'beta'6' SK262002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19933173A DE19933173A1 (de) 1999-07-15 1999-07-15 Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶
PCT/EP2000/006188 WO2001005810A2 (de) 1999-07-15 2000-07-03 CYCLISCHE PEPTIDDERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿6?

Publications (1)

Publication Number Publication Date
SK262002A3 true SK262002A3 (en) 2002-07-02

Family

ID=7914891

Family Applications (1)

Application Number Title Priority Date Filing Date
SK26-2002A SK262002A3 (en) 1999-07-15 2000-07-03 Cyclic peptide derivatives as inhibitors of integrin alpha'v'beta'6'

Country Status (23)

Country Link
EP (2) EP1196433B1 (es)
JP (1) JP2003505395A (es)
KR (1) KR20020010928A (es)
CN (1) CN1361792A (es)
AR (1) AR024742A1 (es)
AT (1) ATE340803T1 (es)
AU (1) AU772782C (es)
BR (1) BR0012418A (es)
CA (1) CA2379022A1 (es)
CZ (1) CZ200226A3 (es)
DE (2) DE19933173A1 (es)
DK (1) DK1196433T3 (es)
ES (1) ES2273703T3 (es)
HK (1) HK1048641A1 (es)
HU (1) HUP0201925A3 (es)
MX (1) MXPA02000465A (es)
NO (1) NO20020176L (es)
PL (1) PL354363A1 (es)
PT (1) PT1196433E (es)
SK (1) SK262002A3 (es)
TW (1) TWI226890B (es)
WO (1) WO2001005810A2 (es)
ZA (1) ZA200201275B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1362865A4 (en) * 2001-02-19 2004-05-06 Takara Bio Inc CYCLIC PEPTIDE
DE10118550A1 (de) * 2001-04-14 2002-10-17 Merck Patent Gmbh Liganden des Integrins alpha¶nu¶beta¶6¶
MXPA06003477A (es) * 2003-10-01 2006-06-05 Merck Patent Gmbh Uso terapuetico de antagonistas de alfavbeta3 y alfavbeta6 integrinas como agentes antifibroticos.
BRPI0417250A (pt) * 2003-12-03 2007-03-06 Scripps Research Inst peptìdios e polinucleotìdio isolados e purificados, anticorpos, vetor, célula hospedeira, métodos de inibição de agregação plaquetária, da ligação do fibrinogênio a plaquetas, de uso de polinucleotìdio para a produção de proteìna e de tratamento de pessoa e composições farmacêuticas
JP2008515886A (ja) 2004-10-06 2008-05-15 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
GB0520068D0 (en) 2005-10-03 2005-11-09 Cancer Res Technology av peptide ligand
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
TW200815474A (en) 2006-08-03 2008-04-01 Astrazeneca Ab Antibodies alphaVbeta6 and uses thereof
EP2784511A1 (en) 2013-03-27 2014-10-01 Universität Zürich Integrin alpha-v-beta6 for diagnosis/prognosis of colorectal carcinoma
WO2017046416A1 (en) 2015-09-18 2017-03-23 Technische Universität München LIGANDS FOR INTEGRIN AVß6, SYNTHESIS AND USES THEREOF
SG11201907820SA (en) 2017-02-28 2019-09-27 Morphic Therapeutic Inc Inhibitors of (alpha-v)(beta-6) integrin
US11046685B2 (en) 2017-02-28 2021-06-29 Morphic Therapeutic, Inc. Inhibitors of (α-v)(β-6) integrin
EP3596105B1 (en) 2017-03-17 2023-12-27 Technische Universität München Ligands for integrin .alpha.v.beta.8, synthesis and uses thereof
GB201706472D0 (en) * 2017-04-24 2017-06-07 Cancer Res Tech Ltd Tumour-targeting peptide variants
US20200071322A1 (en) 2018-08-29 2020-03-05 Morphic Therapeutic, Inc. Inhibiting (alpha-v)(beta-6) integrin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472305A (en) 1983-05-17 1984-09-18 Sterling Drug Inc. Hexapeptide amides
DE4310643A1 (de) 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE19538741A1 (de) 1995-10-18 1997-04-24 Merck Patent Gmbh Cyclopeptidderivate
CN1335853A (zh) * 1998-12-19 2002-02-13 默克专利股份公司 整联蛋白αvβb的抑制剂

Also Published As

Publication number Publication date
CZ200226A3 (cs) 2002-04-17
PT1196433E (pt) 2007-01-31
CA2379022A1 (en) 2001-01-25
ZA200201275B (en) 2003-08-22
HUP0201925A3 (en) 2002-11-28
NO20020176D0 (no) 2002-01-14
AU5823600A (en) 2001-02-05
NO20020176L (no) 2002-01-14
BR0012418A (pt) 2002-03-26
AU772782C (en) 2005-01-27
WO2001005810A2 (de) 2001-01-25
WO2001005810A3 (de) 2001-05-17
MXPA02000465A (es) 2002-07-30
EP1754714A1 (de) 2007-02-21
DE19933173A1 (de) 2001-01-18
HUP0201925A2 (en) 2002-10-28
DK1196433T3 (da) 2007-02-12
HK1048641A1 (zh) 2003-04-11
DE50013525D1 (de) 2006-11-09
PL354363A1 (en) 2004-01-12
AR024742A1 (es) 2002-10-23
TWI226890B (en) 2005-01-21
ES2273703T3 (es) 2007-05-16
ATE340803T1 (de) 2006-10-15
EP1196433B1 (de) 2006-09-27
CN1361792A (zh) 2002-07-31
AU772782B2 (en) 2004-05-06
JP2003505395A (ja) 2003-02-12
KR20020010928A (ko) 2002-02-06
EP1196433A2 (de) 2002-04-17

Similar Documents

Publication Publication Date Title
SK262002A3 (en) Cyclic peptide derivatives as inhibitors of integrin alpha'v'beta'6'
CZ20012212A3 (cs) Peptidická sloučenina, její použití a farmaceutický prostředek, který ji obsahuje
JPH06321988A (ja) 新規直鎖状ペプチド
RU2188205C2 (ru) Циклические азапептиды с ангиогенным действием
SK18722001A3 (sk) Inhibítory integrínu ALFAvBETA6
CA2185394C (en) Biotinderivate
US7759302B2 (en) Peptidic sulfonamides
AU770295B2 (en) AlphaVbetaB integrin inhibitors
MXPA01006229A (es) Inhibidores de la integrina alfa-v-beta-6